DNA damage response inhibitors in pancreatic cancer: progress and challenges

• by Yeyao Wu, Wei Li, Mengyun Wu

• June 15, 2026

Stem Cells More Cost-Effective than Gene Therapy for Sickle Cell Disease

Researchers found gene therapy produced the highest modeled health benefit, but haploidentical stem cell transplantation offered better value at current prices

• June 16, 2026

• 3 min

Prognostic value of an integrated immune-inflammatory phenotype in surgically treated cervical cancer: survival modeling and immunohistochemical validation

• by Lin Ran, Zhaoan Lian, Yong Tian, Li Qin, Yingchun Xiang, Xiaohao Yan, Chengyu Shui

• June 16, 2026

Predicting CAR-T outcomes in R/R DLBCL: a multicenter real-world study of a 5-index model

• by Bin Xue, Huina Lu, Yifan Liu, Ying Lu, Wenjun Zhang, Bing Xiu, Xiu Luo, Li Wang, Wenbin Qian, Aibin Liang, Ping Li

• June 16, 2026